Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba
extract, EGb 761®
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 25, Issue 2, Pages 288-298
Publisher
Wiley
Online
2019-01-16
DOI
10.1111/cns.13095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials
- (2017) Egemen Savaskan et al. INTERNATIONAL PSYCHOGERIATRICS
- Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region
- (2016) C. Chen et al. JOURNAL OF INTERNAL MEDICINE
- Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
- (2015) Bruno Scherrer et al. Journal of Nutrition Health & Aging
- Efficacy ofGinkgo bilobaextract EGb 761®in dementia with behavioural and psychological symptoms: A systematic review
- (2015) Armin von Gunten et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Clinical and imaging features of mixed Alzheimer and vascular pathologies
- (2015) Helena C Chui et al. Alzheimers Research & Therapy
- Dementia and Cognitive Impairment
- (2014) Julie Hugo et al. CLINICS IN GERIATRIC MEDICINE
- Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease
- (2014) N. Kandiah et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy and safety ofGinkgo bilobaextract EGb 761®in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial
- (2014) S. I. Gavrilova et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care
- (2014) Ralf Ihl et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Global Epidemiology of Dementia: Alzheimer’s and Vascular Types
- (2014) Liara Rizzi et al. Biomed Research International
- Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
- (2014) Serge Gauthier et al. Clinical Interventions in Aging
- Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease
- (2013) Nagaendran Kandiah et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
- (2013) Fiona E Matthews et al. LANCET
- Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort
- (2013) M. Ganguli et al. NEUROLOGY
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg
- (2012) Horst Herrschaft et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Epidemiology of dementia in Asia: Insights on prevalence, trends and novel risk factors
- (2012) Joseree-Ann S. Catindig et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
- (2012) Bruno Vellas et al. LANCET NEUROLOGY
- Behavioral and Psychological Symptoms of Dementia
- (2012) J. Cerejeira et al. Frontiers in Neurology
- Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States
- (2011) Walter A. Rocca et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- White Matter Disease Independently Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease in a Clinic Cohort
- (2011) Kalpana Prasad et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Is There a Risk of Bleeding Associated with StandardizedGinkgo bilobaExtract Therapy? A Systematic Review and Meta-analysis
- (2011) Andrea J Kellermann et al. PHARMACOTHERAPY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's disease and other dementias
- (2011) Ralf Ihl et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
- (2010) T Yoshitake et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of Ginkgo biloba in dementia: systematic review and meta-analysis
- (2010) Stefan Weinmann et al. BMC Geriatrics
- Ginkgo bilobaextract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial
- (2009) S. Yancheva et al. AGING & MENTAL HEALTH
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled Trial
- (2008) Steven T. DeKosky JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
- (2008) Raj N Kalaria et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now